Biocon Q3 net dips 13% to Rs 91 crore

Biotech firm Biocon today reported a 13 per cent dip in net profit for October-December quarter at Rs 91 crore and said it will sell 10-15 per cent stake in its research services arm Syngene. The company had clocked Rs 105 crore net profit in the corresponding quarter of the last fiscal.
Share this Video
appinstlBnr
Open in App
Success
This article has been saved